AgeX

$1.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-7.56%) Today

-$0.02 (-1.26%) As of 7:59 PM EDT after-hours

Why Robinhood?

You can buy or sell AgeX and other stocks, options, and ETFs commission-free!

About AGE

AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Read More Its technology platforms include PureStem, UniverCyte, iTR and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. The listed name for AGE is AgeX Therapeutics, Inc.

CEO

Michael D. West

Employees

Headquarters

Alameda, California

Founded

2017

Market Cap

59.92M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

543.36K

High Today

$1.67

Low Today

$1.55

Open Price

$1.66

Volume

356.62K

52 Week High

$3.93

52 Week Low

$0.666

Collections

AGE Earnings

-$0.28

-$0.19

-$0.09

$0.00

Q1 2019

Q2 2019

Q3 2019

Q4 2019

Q1 2020

Q2 2020

Q3 2020

Estimated

— per share

Actual

Expected Nov 12, After Hours